<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Obstructive sleep apnea and other sleep disorders in hospitalized adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Obstructive sleep apnea and other sleep disorders in hospitalized adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Obstructive sleep apnea and other sleep disorders in hospitalized adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Dennis Auckley, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ruth Benca, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy Collop, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2116251431"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Sleep-related breathing disorders such as obstructive sleep apnea (OSA) and central sleep apnea (CSA) occur with increased frequency in certain inpatient populations and may be associated with worse short-term outcomes. OSA is common in the general population, is often undiagnosed, and may first be identified in the inpatient setting. These and other primary sleep disorders are important to recognize, as acute illness and other aspects of hospital admission may aggravate chronic symptoms or bring to light previously unrecognized symptoms.</p><p>This topic will discuss the evaluation, consequences, and management of sleep disorders in hospitalized adults. Sleep apnea in the perioperative setting is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea"</a> and  <a class="medical medical_review" href="/z/d/html/13517.html" rel="external">"Intraoperative management of adults with obstructive sleep apnea"</a> and  <a class="medical medical_review" href="/z/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea"</a>.) </p><p>An approach to poor sleep and insomnia in the inpatient setting is also reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/97849.html" rel="external">"Poor sleep and insomnia in hospitalized adults"</a>.)</p><p class="headingAnchor" id="H292332877"><span class="h1">OBSTRUCTIVE SLEEP APNEA</span><span class="headingEndMark"> — </span>Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder, and most patients are undiagnosed. Breathing pauses and intermittent hypoxemia during directly observed and monitored sleep in the hospital may be the first sign of the disorder.</p><p class="headingAnchor" id="H1630818707"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>The estimated prevalence of OSA in the general population is approximately 15 percent in males and 5 percent in females [<a href="#rid1">1</a>]. OSA is significantly under-recognized in the outpatient setting [<a href="#rid2">2,3</a>], and most patients are undiagnosed [<a href="#rid4">4</a>]. </p><p>The prevalence of OSA in the general inpatient population has not been well studied but it is likely to be higher than in the general population, as the inpatient population is enriched with comorbid conditions associated with OSA, such as obesity, diabetes, hypertension, and cardiovascular diseases [<a href="#rid5">5,6</a>]. Studies using screening questionnaires have found that 40 percent of inpatients ≥50 years old and 66 to 87 percent of inpatients with a body mass index (BMI) ≥30 kg/m<sup>2</sup> score as high-risk for OSA [<a href="#rid7">7-9</a>].</p><p>OSA is particularly common in certain inpatient populations, including the following  (<a class="graphic graphic_table graphicRef107650" href="/z/d/graphic/107650.html" rel="external">table 1</a>) [<a href="#rid10">10-17</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Post-stroke and transient ischemic attack (TIA) patients (see  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke", section on 'Prevalence after stroke'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients admitted to the cardiac care unit, including those with acute decompensated heart failure, acute coronary syndromes, and atrial fibrillation (see  <a class="medical medical_review" href="/z/d/html/7682.html" rel="external">"Sleep-disordered breathing in heart failure", section on 'Prevalence and risk factors'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients admitted with respiratory failure, including COPD exacerbations [<a href="#rid18">18,19</a>], obesity hypoventilation (OHV) exacerbations [<a href="#rid20">20</a>], and COVID-19 pneumonia [<a href="#rid21">21,22</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients admitted who are obese [<a href="#rid8">8</a>] and/or with type 2 diabetes mellitus [<a href="#rid23">23</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients presenting for elective surgery (see  <a class="medical medical_review" href="/z/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients admitted to inpatient psychiatry units [<a href="#rid24">24,25</a>]</p><p></p><p class="headingAnchor" id="H370576139"><span class="h2">Evaluation and diagnosis in the inpatient setting</span><span class="headingEndMark"> — </span>The diagnosis of OSA in the inpatient setting can be logistically difficult due to medical illness, limited resources, and technical challenges with obtaining objective data. Acute illness itself can potentially alter findings on objective testing, and waiting to perform testing until the patient has recovered from their acute illness may yield results more reflective of their chronic disease burden. Nonetheless, there are several options to help stratify risk and prioritize testing in the outpatient or, less commonly, inpatient setting.</p><p class="headingAnchor" id="H4070515369"><span class="h3">History and physical exam</span><span class="headingEndMark"> — </span>The vast majority of inpatients suspected to have OSA by history and physical examination will, when tested, have OSA confirmed by polysomnogram (PSG) or home sleep apnea testing (HSAT) [<a href="#rid26">26,27</a>]. However, clinicians do not routinely evaluate patients for OSA in clinical practice [<a href="#rid8">8,23,28</a>].</p><p>The most common symptoms of OSA are daytime sleepiness, nonrestorative sleep, loud snoring, observed breathing pauses, and waking up choking or gasping  (<a class="graphic graphic_table graphicRef55633" href="/z/d/graphic/55633.html" rel="external">table 2</a>). Physical exam findings that may suggest OSA include obesity, poorly controlled hypertension, large neck circumference, and a crowded or narrow upper airway. (See  <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H1884364041"><span class="h3">Screening questionnaires</span><span class="headingEndMark"> — </span>Questionnaires that can be used to screen for OSA include, among others, the Berlin Questionnaire  (<a class="graphic graphic_table graphicRef91571 graphicRef96753" href="/z/d/graphic/91571.html" rel="external">table 3A-B</a>), the STOP-Bang questionnaire  (<a class="graphic graphic_table graphicRef117089" href="/z/d/graphic/117089.html" rel="external">table 4</a>), and the Sleep Apnea Clinical Score  (<a class="graphic graphic_table graphicRef52357" href="/z/d/graphic/52357.html" rel="external">table 5</a>). Although not rigorously validated in inpatients, several studies have demonstrated their utility in the inpatient setting [<a href="#rid8">8,9,29</a>]. Use of a questionnaire will almost certainly capture more suspected cases than routine clinical care [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Screening questionnaires'</a>.)</p><p class="headingAnchor" id="H14434641"><span class="h3">Overnight oximetry</span><span class="headingEndMark"> — </span>Overnight oximetry is commonly used in inpatient settings and often provides initial clues to the presence of previously unsuspected OSA [<a href="#rid8">8,9,30</a>], although use of supplemental oxygen and poor quality signal can limit reliability.</p><p>In general, a good tracing showing more than 5 to 10 desaturations per hour in patients who are not on supplemental oxygen should prompt consideration of OSA or central sleep apnea (CSA). Very frequent or severe hypoxemia during sleep may signal a need to prioritize diagnostic sleep apnea testing and treatment, depending on the specifics of the clinical situation.</p><p>Of note, overnight oximetry, which can provide an oxygen desaturation index (ODI, number of desaturations per hour of recording), is not considered an adequate diagnostic test by most, if not all, insurers in order to obtain a prescription for positive airway pressure therapy. This technology is therefore best used as a risk-stratifying tool rather than a diagnostic tool. Additional variables that can affect performance include the degree of oxygen desaturation required to determine an event (3 versus 4 percent), the ODI cut-off used (ie, &gt;5, &gt;10, or &gt;15) to identify significant sleep-disordered breathing, the definition of hypopnea used on the confirmatory PSG, whether or not the patient obtains adequate sleep on the testing night, and technical and interpreter variability [<a href="#rid31">31,32</a>]. Use of a high-resolution pulse oximeter may help to reduce some of the technical issues [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/z/d/html/99553.html" rel="external">"Polysomnography in the evaluation of sleep-disordered breathing in adults", section on 'Measures of sleep-disordered breathing severity'</a>.)</p><p class="headingAnchor" id="H113335088"><span class="h3">Portable sleep apnea testing</span><span class="headingEndMark"> — </span>Home sleep apnea testing (HSAT) using a portable, unattended device is a valid alternative to in-laboratory PSG for diagnosing uncomplicated OSA in the outpatient setting, primarily when pre-test suspicion for moderate to severe OSA is high [<a href="#rid34">34</a>].</p><p>HSAT may be available in some centers for inpatient testing. Pending additional validation studies in patients with significant comorbidities, selection of inpatients for HSAT should be approached on a case-by-case basis in conjunction with a pulmonologist or sleep specialist.</p><p>Importantly, HSAT has not been extensively studied or validated in outpatients at risk for more complicated types of sleep-disordered breathing (eg, CSA and/or hypoventilation), including those with heart failure, obstructive lung disease, and neuromuscular disease with respiratory impairment [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/z/d/html/7694.html" rel="external">"Home sleep apnea testing for obstructive sleep apnea in adults"</a>.)</p><p>Despite these caveats, limited data in the acute cardiac disease population, in post-stroke patients, and in general medical patients suggest that testing with type III HSAT devices is feasible in the inpatient setting and may be reasonably accurate [<a href="#rid10">10,36-40</a>]. Type III devices include monitoring of at least four channels, including two that assess respiration  (<a class="graphic graphic_figure graphicRef77569" href="/z/d/graphic/77569.html" rel="external">figure 1</a>). HSAT devices using peripheral arterial tonometry have been compared with type III devices in patients admitted with myocardial infarctions and found to have moderate levels of agreement [<a href="#rid41">41</a>], though further study is needed. (See  <a class="medical medical_review" href="/z/d/html/7694.html" rel="external">"Home sleep apnea testing for obstructive sleep apnea in adults", section on 'Sleep monitoring devices'</a>.)</p><p class="headingAnchor" id="H3671042468"><span class="h3">Polysomnography</span><span class="headingEndMark"> — </span>PSG remains the gold standard for diagnosing OSA and determining the severity of OSA (as measured by the apnea-hypopnea index [AHI]), but implementing PSG testing in the hospital environment can be challenging. A full PSG may be considered intrusive in patients already suffering from poor sleep, thus limiting sleep time available for analysis. Additional challenges include disturbances to sleep due to ongoing inpatient care (especially if support sleep staff are not directly on site), resource requirements, logistics, and issues of reimbursement.</p><p>Nonetheless, inpatient PSG may be an option in some institutions. A number of studies have shown the feasibility of performing PSG in a range of inpatient settings [<a href="#rid10">10,26,42,43</a>]. Local institutional policies and resources may determine whether or not inpatient PSG is practical.</p><p class="headingAnchor" id="H1781148921"><span class="h2">Adverse inpatient outcomes</span><span class="headingEndMark"> — </span>There are robust data linking a known diagnosis of OSA to worse short-term outcomes in the postoperative and post-stroke settings. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea", section on 'Perioperative complications'</a>.)</p><p>In addition, at least two large database studies have found worse inpatient outcomes in patients who carry a diagnosis of OSA compared with those without OSA [<a href="#rid44">44,45</a>]. In a study of over 55 million pregnancy-related inpatient discharges in the Nationwide Inpatient Sample database, OSA was associated with increased risk of multiple adverse outcomes, including preeclampsia (odds ratio [OR] 2.5), eclampsia (OR 5.4), cardiomyopathy (OR 9), pulmonary embolism (OR 4.5), and in-hospital mortality (OR 5) [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/z/d/html/14202.html" rel="external">"Obstructive sleep apnea in pregnancy", section on 'Outcomes'</a>.)</p><p>In another multicenter retrospective study of &gt;250,000 patients admitted for pneumonia, 6 percent of patients had an established diagnosis of OSA [<a href="#rid45">45</a>]. After adjusting for potential confounders, OSA was associated with higher rates of ICU transfer (OR 1.5), intubation (OR 1.7), and a longer length of stay, but lower mortality (OR 0.9). Further studies are needed to better understand the mechanisms underlying these risks, including potentially modifiable factors such as exposure to opioids or other drugs that may acutely worsen OSA disease severity.</p><p>Evidence also suggests that a new diagnosis of OSA by objective testing made during hospital admission is associated with worse outcomes, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Higher rates of rapid response team activation during admission [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Higher CHADS2 score during atrial fibrillation admission [<a href="#rid12">12</a>] and increased rates of arrhythmias (two- to threefold) in patients &gt;60 years old admitted with subacute myocardial infarction [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Worse composite cardiovascular outcomes after admission for myocardial infarction (HR 5.4 for patients with AHI &gt;30) [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Higher rates of readmission and mortality at 14 months following congestive heart failure (CHF) admission (hazard ratio [HR] 2.9 for patients with an ODI 4 percent &gt;5) [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Greater mortality at three years following CHF admission (OR 1.5) [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Higher rates of readmission at 30 days after a COPD exacerbation (OR 6 to 10 for moderate to severe OSA) [<a href="#rid18">18</a>].</p><p></p><p class="headingAnchor" id="H2030059311"><span class="h2">Management</span><span class="headingEndMark"> — </span>Positive airway pressure (PAP) therapy is the mainstay of treatment for OSA. For most patients with OSA, continuous positive airway pressure (CPAP) is the first-line treatment; alternative modes such as bilevel positive airway pressure (BPAP) can be used in selected patients. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Positive airway pressure (PAP) therapy'</a>.)</p><p>Emerging data support earlier intervention with PAP therapy in patients admitted to the hospital who are found to have sleep apnea. Potential benefits include reduced rapid response team activation and decreased post-discharge readmissions for patients with heart disease and chronic obstructive pulmonary disease (COPD) [<a href="#rid9">9,11,46</a>].</p><p class="headingAnchor" id="H1007568934"><span class="h3">Patients with known OSA who use PAP at home</span><span class="headingEndMark"> — </span>Inpatients with a previously established diagnosis of OSA who use CPAP or BPAP at home should be encouraged to use it in the hospital, as their condition allows. While some acute medical issues may preclude PAP therapy (eg, nausea and vomiting, use of a nasogastric tube in some cases, upper gastrointestinal bleeding, facial trauma or infection, mental status changes), most others do not. Oxygen therapy does not preclude use of PAP, as oxygen can be delivered in conjunction with PAP.</p><p>However, studies suggest that inpatient CPAP use in those with known OSA on PAP therapy is quite variable, ranging from 6 to 64 percent depending on the study [<a href="#rid6">6,50-52</a>]. Aside from acute medical issues, factors that may contribute to a low rate of inpatient CPAP use include lack of awareness or understanding of OSA and PAP therapy on the part of clinicians and respiratory therapists and a lack of available PAP settings during admission [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H3935528339"><span class="h3">Patients with known OSA who use other therapies at home</span><span class="headingEndMark"> — </span>Most patients who use an alternative therapy for OSA at home, such as oral appliances or implanted hypoglossal nerve stimulation, should be encouraged to use the device in the inpatient setting.</p><p>In some cases, PAP therapy may be preferable during hospitalization. Examples include patients whose OSA is poorly controlled with their home therapy, patients who did not bring their oral appliance or hypoglossal nerve stimulator activator to the hospital with them, and patients with conditions associated with worsening of their underlying OSA, for which the home therapy may not compensate (eg, new stroke, substantial new opioid requirement).</p><p class="headingAnchor" id="H1022814685"><span class="h3">Patients with newly diagnosed or previously untreated OSA</span><span class="headingEndMark"> — </span>Inpatient initiation of PAP therapy in patients with newly diagnosed or previously untreated OSA can be considered on a case-by-case basis, but there are limited outcomes data to support widespread adoption of this practice [<a href="#rid46">46,54</a>]. There are also several potential drawbacks to consider in the inpatient setting.</p><p class="bulletIndent1"><span class="glyph">●</span>One of the major problems with CPAP therapy in the outpatient setting is adherence, and similar problems may be encountered in the hospital setting. Data in surgical patients suggest that adherence with CPAP initiated perioperatively is quite poor following surgery [<a href="#rid55">55-57</a>]. Poor compliance with newly initiated PAP therapy during admission has also been reported in medical patients [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients may not be inclined to start new CPAP therapy during acute medical illness. In addition, hospitals may lack optimal staff support for first-time CPAP initiation. CPAP is often administered in the hospital by nursing personnel or respiratory therapists, who may not have the time or expertise of a sleep technician for mask fittings, pressure adjustments, and other troubleshooting techniques. (See  <a class="medical medical_review" href="/z/d/html/7702.html" rel="external">"Assessing and managing nonadherence with continuous positive airway pressure (CPAP) for adults with obstructive sleep apnea", section on 'First-line interventions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determining and optimizing PAP pressure settings may be challenging. While auto-adjusting pressure devices may be appropriate for some patients, those at risk for CSA or hypoventilation may not be well suited for this approach unless advanced technologies are available (eg, adaptive servo-ventilation or volume-assured pressure support). (See  <a class="medical medical_review" href="/z/d/html/105590.html" rel="external">"Mode selection for positive airway pressure titration in adult patients with central sleep apnea syndromes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is a financial cost associated with starting CPAP therapy in the hospital, and data on the economics of inpatient initiation of PAP therapy are lacking.</p><p></p><p>Despite these limitations, inpatient initiation of PAP therapy may be justified in selected patients, based on limited data that initiating CPAP following a new diagnosis of OSA may improve outcomes in specific inpatient groups. Such groups include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Selected postoperative patients with previously untreated OSA. (See  <a class="medical medical_review" href="/z/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea", section on 'Positive airway pressure therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Post-stroke patients with newly diagnosed OSA, particularly in those with an AHI &gt;15 events per hour. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with newly diagnosed OSA in the setting of acute decompensated heart failure or other cardiac problems. In a pilot study of 46 patients admitted for acute decompensated heart failure who were diagnosed with OSA (AHI &gt;15) within the first 48 hours of admission, patients randomly assigned to initiation of auto-adjusting bilevel pressure support had improved ejection fraction (by 5 percent) compared with those assigned to standard of care [<a href="#rid59">59</a>]. Follow-up data suggest that this benefit is only realized in those adherent to therapy [<a href="#rid58">58</a>]. Other data suggests that initiation of auto-adjusting CPAP following the diagnosis of OSA (AHI &gt;5) in patients admitted for congestive heart failure, myocardial infarction, or an arrhythmia decreases 30-day [<a href="#rid36">36,60</a>] and 6-month [<a href="#rid58">58</a>] readmission rates in those who were adherent to therapy. (See  <a class="medical medical_review" href="/z/d/html/7682.html" rel="external">"Sleep-disordered breathing in heart failure", section on 'Management'</a>.)</p><p></p><p>Even in these groups, deciding whether or not to initiate PAP therapy requires careful consideration of the underlying illness, the severity of the sleep-disordered breathing as suggested by the frequency of respiratory events and degree of associated hypoxemia (based on objective testing), and the patient's willingness and appropriateness for starting PAP therapy in the hospital. Consultation with a pulmonologist or sleep specialist is encouraged in cases of uncertainty, or when PAP therapy is planned.</p><p class="headingAnchor" id="H2997518043"><span class="h3">Review of concomitant medications</span><span class="headingEndMark"> — </span>The medication list should be carefully reviewed in patients with known or suspected OSA to ensure that medications that may precipitate or worsen OSA are minimized or eliminated. Specifically, sedatives such as benzodiazepines, barbiturates, and high-dose opioids should be avoided if possible. If required, the lowest effective dose should be used. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Alcohol, sedating, and select medications avoidance'</a>.)</p><p class="headingAnchor" id="H2391153242"><span class="h3">Role of nocturnal oxygen</span><span class="headingEndMark"> — </span>Oxygen may be used to minimize OSA-related hypoxemia but is not considered a primary therapy for OSA. Oxygen therapy has not been shown to alter long-term outcomes in patients with OSA and may increase the duration of apneas and hypopneas [<a href="#rid61">61</a>]. Care should also be used when considering oxygen therapy for OSA in inpatients at risk for hypoventilation (eg, obesity-associated hypoventilation) [<a href="#rid62">62,63</a>]. An evaluation for baseline hypercapnia should be considered before starting nocturnal oxygen in such patients. (See  <a class="medical medical_review" href="/z/d/html/7713.html" rel="external">"Treatment and prognosis of the obesity hypoventilation syndrome", section on 'Avoidance of alcohol and sedatives'</a>.)</p><p>In the absence of hypercapnia risk, nocturnal oxygen can be considered as a "bridge," pending more appropriate OSA therapy, in order to avoid severe nocturnal hypoxemia in selected cases. This may be most appropriate for patients with conditions that may be aggravated by significant hypoxemia, such as acute stroke or myocardial infarction, though data supporting this strategy are lacking at present.</p><p class="headingAnchor" id="H1002784349"><span class="h2">Post-discharge follow-up</span><span class="headingEndMark"> — </span>Regardless of whether or not PAP is initiated during an acute hospital stay, patients with OSA require appropriate outpatient follow-up, as OSA is a chronic disease. The urgency with which to initiate PAP or other therapies for OSA in patients with newly diagnosed, untreated OSA depends on several factors, including OSA disease severity and symptoms, comorbidities, and risk factors for adverse outcomes. Patients admitted with heart failure, COPD exacerbation, or stroke should be considered target populations for more aggressive and earlier intervention with PAP therapy [<a href="#rid9">9,11,64,65</a>]. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke", section on 'Management'</a> and  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Goals of PAP therapy'</a>.)</p><p>Patients who have been started on PAP during hospitalization should generally be seen by their primary care or sleep medicine clinician within two to four weeks of discharge to review symptoms, assess PAP adherence, and troubleshoot any difficulties with CPAP use. If a diagnostic sleep study has not been performed prior to initiation of therapy, then either an in-laboratory PSG or HSAT should be obtained in order to confirm the type and severity of the sleep-disordered breathing. Patients with persistent symptoms (eg, daytime sleepiness) despite regular use of PAP should undergo a formal titration study via either in-laboratory PSG or HSAT in order to determine the adequacy of therapy. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Follow-up'</a>.)</p><p>Alternative therapies for OSA, such as surgical intervention, oral appliances, nasal resistive valves, and negative pressure devices, are generally not feasible to initiate in acutely ill patients but can be considered in the outpatient setting once the patient is stable. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Patients who fail, do not tolerate, or decline PAP therapy'</a>.)</p><p class="headingAnchor" id="H1727638264"><span class="h1">CENTRAL SLEEP APNEA</span><span class="headingEndMark"> — </span>Central sleep apnea (CSA) is much less common than obstructive sleep apnea (OSA), and the therapeutic options are highly varied, depending on the underlying cause. As such, the literature regarding the prevalence, diagnosis, consequences, and management of CSA in hospitalized patients remains quite sparse.</p><p>CSA can be a primary disorder, the manifestation of a variety of underlying medical conditions (eg, stroke, congestive heart failure, neuromuscular disease), the result of certain medications (eg, opioids), or even the result of positive airway pressure (PAP) therapy itself in patients with predominantly obstructive sleep apnea OSA (eg, treatment-emergent CSA). (See  <a class="medical medical_review" href="/z/d/html/7701.html" rel="external">"Central sleep apnea: Risk factors, clinical presentation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H2497136834"><span class="h2">High-risk groups</span><span class="headingEndMark"> — </span>The prevalence of CSA in the general medical inpatient population is unknown. Specific inpatient groups with an increased risk of CSA include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Post-stroke patients – Like OSA, CSA occurs with increased frequency in post-stroke patients compared with expected rates in the general population. Meta-analyses of sleep apnea following stroke found CSA or Cheyne-Stokes breathing as the primary form of sleep-disordered breathing in 7 to 10 percent of patients [<a href="#rid14">14,66</a>]. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with congestive heart failure (CHF) – CSA with Cheyne-Stokes breathing is common in outpatients with CHF and in patients hospitalized with acute decompensated heart failure [<a href="#rid10">10,36,67,68</a>]. Prevalence rates in inpatient samples range from 18 to 76 percent, with the wide range likely reflecting differences in heart failure severity, whether scoring of central hypopneas was included, and the study population size. (See  <a class="medical medical_review" href="/z/d/html/7682.html" rel="external">"Sleep-disordered breathing in heart failure"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who chronically use opioids – In a study of 70 consecutive patients admitted to the hospital for <a class="drug drug_general" data-topicid="9170" href="/z/d/drug information/9170.html" rel="external">buprenorphine</a>/<a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">naloxone</a> therapy to treat opioid dependency, 63 percent exhibited predominantly CSA, including 39 percent with at least moderate to severe ataxic breathing, also known as Biot's respiration [<a href="#rid69">69</a>]. (See  <a class="medical medical_review" href="/z/d/html/97859.html" rel="external">"Sleep-disordered breathing in patients chronically using opioids", section on 'Prevalence'</a>.)</p><p></p><p class="headingAnchor" id="H179321296"><span class="h2">Diagnosis in the inpatient setting</span><span class="headingEndMark"> — </span>Establishing an accurate diagnosis of CSA in the inpatient setting can be more difficult than diagnosing OSA, not only for the logistical reasons reviewed above (see <a class="local">'Evaluation and diagnosis in the inpatient setting'</a> above), but also due to the unreliability of many screening and testing modalities for CSA. There are limited options:</p><p class="bulletIndent1"><span class="glyph">●</span>History and physical exam – Aside from recognizing clinical conditions and medications that may increase the risk of CSA, history and physical examination are generally poorly predictive of CSA. Symptoms of CSA overlap significantly with those of OSA as well as those of underlying comorbidities, and there are no defining physical examination findings (with the exception of witnessed Cheyne-Stokes respirations). (See  <a class="medical medical_review" href="/z/d/html/7701.html" rel="external">"Central sleep apnea: Risk factors, clinical presentation, and diagnosis", section on 'Clinical findings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Screening questionnaires – There are no validated inpatient screening questionnaires for CSA.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Overnight oximetry – Nocturnal oximetry with continuous recording can provide an oxygen desaturation index (ODI) that can help to identify sleep-disordered breathing, but it is not reliable for distinguishing central from obstructive respiratory events [<a href="#rid68">68,70</a>]. (See <a class="local">'Overnight oximetry'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Home sleep apnea testing (HSAT) – Validation studies of HSAT devices have generally excluded patients at risk for CSA, including patients with significant heart failure and neuromuscular disease with respiratory impairment [<a href="#rid35">35</a>]. In addition, the American Academy of Sleep Medicine (AASM) clinical guideline on the use of HSAT devices currently recommends against the use of HSAT to diagnose CSA [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1">Nonetheless, there are limited data in patients with acute decompensated heart failure suggesting that testing with type III HSAT devices (which include monitoring of at least four channels, of which two assess respiration) is feasible and may be reasonably accurate for CSA [<a href="#rid39">39,71</a>]. However, additional validation of these devices for the diagnosis of CSA is warranted before routine use can be recommended.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Polysomnography (PSG) – PSG is the gold standard method for diagnosing CSA. As reviewed above, there are potential logistical and financial limitations to performing inpatient PSG; however, studies suggest that inpatient PSG may be feasible in a range of inpatient settings [<a href="#rid10">10,26,42,43</a>], including in cardiac patients with CSA [<a href="#rid72">72</a>], though availability may be limited by institutional resources. (See <a class="local">'Polysomnography'</a> above.)</p><p></p><p class="headingAnchor" id="H517512610"><span class="h2">Potential consequences</span><span class="headingEndMark"> — </span>Observational studies of patients with CSA due to heart failure suggest that CSA is associated with impaired quality of life [<a href="#rid73">73</a>] and increased mortality [<a href="#rid74">74,75</a>], although the data are not entirely consistent [<a href="#rid76">76,77</a>]. Little is known about the prognosis for patients with CSA secondary to other comorbid diseases.</p><p>Studies in heart failure patients with a new diagnosis of CSA during inpatient admission have found an association between CSA and more frequent and complex arrhythmias [<a href="#rid78">78</a>], six-month cardiac readmission rates [<a href="#rid71">71</a>], risk of cardiovascular death at two years (hazard ratio [HR] 1.3) [<a href="#rid78">78</a>], and all-cause mortality [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H3419338162"><span class="h2">Management</span><span class="headingEndMark"> — </span>Patients with a known diagnosis of CSA who are admitted to the hospital should be encouraged to continue with their primary therapy, whenever possible. Like OSA, PAP therapy is the most common treatment for CSA. (See  <a class="medical medical_review" href="/z/d/html/7675.html" rel="external">"Central sleep apnea: Treatment"</a>.)</p><p>Definitive statements about whether or not to intervene for newly diagnosed CSA during an inpatient admission are not possible, due to the varied underlying etiologies that can lead to CSA as well as the considerable uncertainty regarding the optimal therapy for many types of CSA. Management considerations in specific patient populations include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>For inpatients with CSA associated with heart failure, primary interventions include optimizing cardiac function and use of oxygen therapy if patients are hypoxemic at night [<a href="#rid79">79</a>]. Initiation of PAP therapy upon discharge may improve short-term outcomes [<a href="#rid11">11</a>]. Caution is recommended when considering the empiric initiation of certain modes of PAP therapy, based on data showing worse outcomes with adaptive servo-ventilation (ASV) in patients with symptomatic heart failure and reduced ejection fraction [<a href="#rid80">80,81</a>]. (See  <a class="medical medical_review" href="/z/d/html/7682.html" rel="external">"Sleep-disordered breathing in heart failure"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For post-stroke patients with primarily newly diagnosed CSA, close observation is reasonable for most patients in the inpatient setting, as the CSA often resolves during recovery from the stroke [<a href="#rid82">82</a>]. Initiation of PAP therapy can be considered in the inpatient setting on an individual basis. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with CSA associated with opioid use, minimizing or discontinuing opioid therapy is considered first-line therapy, where possible. If this is not feasible, PAP therapy is an option in selected patients, although given the complexities of care and paucity of data regarding benefits, this should generally be addressed and coordinated on an outpatient basis. (See  <a class="medical medical_review" href="/z/d/html/97859.html" rel="external">"Sleep-disordered breathing in patients chronically using opioids", section on 'Treatment'</a>.)</p><p></p><p class="headingAnchor" id="H911433992"><span class="h1">OTHER SLEEP DISORDERS</span><span class="headingEndMark"> — </span>A variety of other primary sleep disorders may be encountered in the inpatient setting. These fall into the broad categories of central disorders of hypersomnolence (eg, narcolepsy), circadian rhythm sleep-wake disorders (eg, delayed sleep-wake phase syndrome), parasomnias (eg, sleep walking, rapid eye movement [REM] sleep behavior disorder), and sleep-related movement disorders (eg, restless legs syndrome [RLS]). (See  <a class="medical medical_review" href="/z/d/html/7700.html" rel="external">"Classification of sleep disorders"</a>.)</p><p>While some of these conditions are common in the general population and occur with increased frequency in patients with multiple comorbidities (eg, RLS), others have low prevalence rates and may rarely be seen in the inpatient setting (eg, narcolepsy). There are sparse data on inpatient prevalence, consequences during hospitalization, or management strategies during admission to help guide care. Select issues to consider and some common sense approaches include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central disorders of hypersomnolence such as narcolepsy</strong> – Patients with narcolepsy may have increased symptoms during hospitalization and may be at risk for cardiopulmonary complications in the perioperative setting [<a href="#rid83">83-86</a>]. Potential mechanisms include disease-related autonomic instability, altered pain sensitivity, medication interactions, and medication withdrawal [<a href="#rid87">87</a>]. Based on these considerations, the following are recommended:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continue stimulant therapy unless otherwise contraindicated by the clinical situation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Resume stimulant therapy early in the postoperative period.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continue medications for cataplexy unless otherwise contraindicated by the clinical situation. Abrupt withdrawal of certain medications can lead to a state of status cataplecticus [<a href="#rid88">88</a>] or significant mental status changes [<a href="#rid89">89</a>]. (See  <a class="medical medical_review" href="/z/d/html/7681.html" rel="external">"Treatment of narcolepsy in adults", section on 'Antidepressants for cataplexy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluate safety and use fall risk precautions in patients with frequent cataplexy. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Circadian sleep-wake rhythm disorders</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Be attuned to how a delayed or advanced sleep phase may affect sleep during admission. Patients with an underlying circadian sleep-wake rhythm disorder (eg, delayed sleep-wake phase syndrome in adolescents or young adults, advanced sleep-wake phase syndrome in older adults) may develop significant sleep deprivation during admission when sleep is limited to conventional nighttime hours not in line with their usual sleep habits. (See  <a class="medical medical_review" href="/z/d/html/97844.html" rel="external">"Overview of circadian rhythm sleep-wake disorders"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continue any chronic chronotropic therapy during the admission, such as melatonin or light therapy where possible. (See  <a class="medical medical_review" href="/z/d/html/97845.html" rel="external">"Delayed sleep-wake phase disorder", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parasomnias</strong> – Parasomnias may be seen in the inpatient setting resulting from an illness (eg, stroke) or medication side effect, the cause for admission (eg, serious injury in sleep), or may manifest or worsen during admission for a separate medical illness [<a href="#rid90">90</a>]. (See  <a class="medical medical_review" href="/z/d/html/97850.html" rel="external">"Approach to abnormal movements and behaviors during sleep"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Encourage adequate sleep and consider need for fall risk prevention from sleep-related behaviors. Avoid sleep disruption as much as possible, as sleep deprivation is a common trigger for parasomnias.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continue medications used for control of a known parasomnia unless otherwise contraindicated by the clinical situation. Abrupt withdrawal of these medications can precipitate the parasomnia [<a href="#rid91">91</a>], which can place the patient at risk for injury. (See  <a class="medical medical_review" href="/z/d/html/97851.html" rel="external">"Disorders of arousal from non-rapid eye movement sleep in adults"</a> and  <a class="medical medical_review" href="/z/d/html/14894.html" rel="external">"Rapid eye movement sleep behavior disorder"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with REM sleep behavior disorder, use melatonin 5 to 10 mg at night when benzodiazepines cannot be given. (See  <a class="medical medical_review" href="/z/d/html/14894.html" rel="external">"Rapid eye movement sleep behavior disorder", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sleep-related movement disorders such as RLS</strong> – RLS symptoms can worsen in the inpatient and perioperative setting due to medication changes, forced immobilization, blood loss, and sleep deprivation. Worsening symptoms can adversely impact recovery from illness and/or surgery and increase length of stay [<a href="#rid86">86,92</a>]. We suggest the following approach:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continue medications used for control of the movement disorders, such as dopamine agonists, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, or <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">pregabalin</a>, unless otherwise contraindicated by the clinical situation. Take care to administer at the correct time and avoid skipping doses.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid medications known to precipitate or aggravate RLS (eg, first-generation antihistamines, <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a>, <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">haloperidol</a>, selective serotonin reuptake inhibitors).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Limit blood draws whenever feasible, as phlebotomy-induced iron deficiency can worsen RLS and periodic limb movements in sleep. (See  <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">"Management of restless legs syndrome and periodic limb movement disorder in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Encourage ambulation, stretching, and use of sequential compression devices.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid immobility, sleep disruption/deprivation, and inadequate pain control.</p><p></p><p>Many of the common sleep disorders may be aggravated by acute illness, as well as by substance abuse or withdrawal. If a known sleep disorder becomes a significant problem during inpatient admission, consultation with a specialist in sleep medicine should be considered. Similarly, if a primary sleep disorder is suspected during inpatient admission, involvement of a sleep specialist may be useful to aid in diagnosis and management. Specifics of the clinical situation should dictate whether this occurs while the patient is an inpatient or as an outpatient.</p><p class="headingAnchor" id="H2253226683"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113310.html" rel="external">"Society guideline links: Sleep-related breathing disorders in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/113024.html" rel="external">"Society guideline links: Parasomnias, hypersomnias, and circadian rhythm disorders"</a>.)</p><p class="headingAnchor" id="H3572988226"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstructive sleep apnea</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prevalence and impact</strong> – Obstructive sleep apnea (OSA) is increasingly recognized in the inpatient setting and may be associated with worse short-term outcomes. This may be especially true for patients admitted with cardiovascular disease and stroke. (See <a class="local">'Prevalence'</a> above and <a class="local">'Adverse inpatient outcomes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation and diagnosis</strong> – The majority of inpatients suspected of having OSA by history and physical examination will be confirmed to have OSA once tested by polysomnography (PSG) or home sleep apnea testing (HSAT). Inpatient diagnostic sleep testing is logistically challenging but can be accomplished at some centers. (See <a class="local">'Evaluation and diagnosis in the inpatient setting'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Management</strong> – Inpatients with a previously established diagnosis of OSA who use positive airway pressure (PAP) therapy at home should be encouraged to use it in the hospital, as their condition allows.</p><p></p><p class="bulletIndent2">Inpatient initiation of PAP therapy in patients with newly diagnosed or previously untreated OSA can be considered on a case-by-case basis, but there are inadequate outcomes data at this time to support widespread adoption of this practice. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central sleep apnea </strong>–<strong> </strong>Though less common than OSA, central sleep apnea (CSA) occurs with increased frequency in certain inpatient groups, including post-stroke patients, patients with acute decompensated heart failure, and patients who chronically use opioids. Management of CSA in the hospital varies according to the underlying cause. (See <a class="local">'Central sleep apnea'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other sleep disorders</strong> – Many other less common primary sleep disorders may potentially require attention during inpatient admission. Consultation with a specialist in sleep medicine may be useful if there is uncertainty about how best to evaluate and manage existing or suspected sleep disorders in the inpatient setting. (See <a class="local">'Other sleep disorders'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177:1006.</a></li><li><a class="nounderline abstract_t">Senthilvel E, Auckley D, Dasarathy J. Evaluation of sleep disorders in the primary care setting: history taking compared to questionnaires. J Clin Sleep Med 2011; 7:41.</a></li><li><a class="nounderline abstract_t">Namen AM, Wymer A, Case D, Haponik EF. Performance of sleep histories in an ambulatory medicine clinic: impact of simple chart reminders. Chest 1999; 116:1558.</a></li><li><a class="nounderline abstract_t">Redline S, Sotres-Alvarez D, Loredo J, et al. Sleep-disordered breathing in Hispanic/Latino individuals of diverse backgrounds. The Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 2014; 189:335.</a></li><li><a class="nounderline abstract_t">Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med 2008; 2:349.</a></li><li><a class="nounderline abstract_t">Spurr K, Morrison DL, Graven MA, et al. Analysis of hospital discharge data to characterize obstructive sleep apnea and its management in adult patients hospitalized in Canada: 2006 to 2007. Can Respir J 2010; 17:213.</a></li><li><a class="nounderline abstract_t">Shear TC, Balachandran JS, Mokhlesi B, et al. Risk of sleep apnea in hospitalized older patients. J Clin Sleep Med 2014; 10:1061.</a></li><li><a class="nounderline abstract_t">Sharma S, Mather PJ, Efird JT, et al. Obstructive Sleep Apnea in Obese Hospitalized Patients: A Single Center Experience. J Clin Sleep Med 2015; 11:717.</a></li><li><a class="nounderline abstract_t">Sharma S, Mukhtar U, Kelly C, et al. Recognition and Treatment of Sleep-Disordered Breathing in Obese Hospitalized Patients May Improve Survival. The HoSMed Database. Am J Med 2017; 130:1184.</a></li><li><a class="nounderline abstract_t">Khayat RN, Jarjoura D, Patt B, et al. In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure: report of prevalence and patient characteristics. J Card Fail 2009; 15:739.</a></li><li><a class="nounderline abstract_t">Khayat R, Jarjoura D, Porter K, et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J 2015; 36:1463.</a></li><li><a class="nounderline abstract_t">Szymanski FM, Filipiak KJ, Platek AE, et al. Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation. Sleep Breath 2015; 19:531.</a></li><li><a class="nounderline abstract_t">Mehra R, Principe-Rodriguez K, Kirchner HL, Strohl KP. Sleep apnea in acute coronary syndrome: high prevalence but low impact on 6-month outcome. Sleep Med 2006; 7:521.</a></li><li><a class="nounderline abstract_t">Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6:131.</a></li><li><a class="nounderline abstract_t">Correia LC, Souza AC, Garcia G, et al. Obstructive sleep apnea affects hospital outcomes of patients with non-ST-elevation acute coronary syndromes. Sleep 2012; 35:1241.</a></li><li><a class="nounderline abstract_t">Mokhlesi B, Hovda MD, Vekhter B, et al. Sleep-disordered breathing and postoperative outcomes after elective surgery: analysis of the nationwide inpatient sample. Chest 2013; 144:903.</a></li><li><a class="nounderline abstract_t">Hallowell PT, Stellato TA, Schuster M, et al. Potentially life-threatening sleep apnea is unrecognized without aggressive evaluation. Am J Surg 2007; 193:364.</a></li><li><a class="nounderline abstract_t">Naranjo M, Willes L, Prillaman BA, et al. Undiagnosed OSA May Significantly Affect Outcomes in Adults Admitted for COPD in an Inner-City Hospital. Chest 2020; 158:1198.</a></li><li><a class="nounderline abstract_t">Turcani P, Skrickova J, Pavlik T, et al. The prevalence of obstructive sleep apnea in patients hospitalized for COPD exacerbation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159:422.</a></li><li><a class="nounderline abstract_t">Msaad S, Gargouri R, Kotti A, et al. Characteristics of Obese Patients with Acute Hypercapnia Respiratory Failure Admitted in the Department of Pneumology: An Observational Study of a North African Population. Sleep Disord 2022; 2022:5398460.</a></li><li><a class="nounderline abstract_t">Perger E, Soranna D, Pengo M, et al. Sleep-disordered Breathing among Hospitalized Patients with COVID-19. Am J Respir Crit Care Med 2021; 203:239.</a></li><li><a class="nounderline abstract_t">Goyal A, Saxena K, Kar A, et al. Obstructive sleep apnea is highly prevalent in COVID19 related moderate to severe ARDS survivors: findings of level I polysomnography in a tertiary care hospital. Sleep Med 2022; 91:226.</a></li><li><a class="nounderline abstract_t">Zhang P, Zhang R, Zhao F, et al. The prevalence and characteristics of obstructive sleep apnea in hospitalized patients with type 2 diabetes in China. J Sleep Res 2016; 25:39.</a></li><li><a class="nounderline abstract_t">Tanielian M, Doghramji K, Certa K. Obstructive Sleep Apnea in Psychiatric Inpatients. J Nerv Ment Dis 2020; 208:190.</a></li><li><a class="nounderline abstract_t">Talih FR, Ajaltouni JJ, Tamim HM, Kobeissy FH. Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients. Neuropsychiatr Dis Treat 2017; 13:1193.</a></li><li><a class="nounderline abstract_t">Goring K, Collop N. Sleep disordered breathing in hospitalized patients. J Clin Sleep Med 2008; 4:105.</a></li><li><a class="nounderline abstract_t">Al-Jawder S, Bahammam A. Utility of daytime polysomnography for in-patients with suspected sleep-disordered breathing. Neurol Neurochir Pol 2009; 43:140.</a></li><li><a class="nounderline abstract_t">Namen AM, Landry SH, Case LD, et al. Sleep histories are seldom documented on a general medical service. South Med J 2001; 94:874.</a></li><li><a class="nounderline abstract_t">Loo G, Hein T, Tai BC, et al. Screening of hospitalized patients at high risk of obstructive sleep apnea in general cardiology service. Int J Cardiol 2013; 164:368.</a></li><li><a class="nounderline abstract_t">Nader NZ, Steinel JA, Auckley DH. Newly identified obstructive sleep apnea in hospitalized patients: analysis of an evaluation and treatment strategy. J Clin Sleep Med 2006; 2:431.</a></li><li><a class="nounderline abstract_t">Ramsey R, Mehra R, Strohl KP. Variations in physician interpretation of overnight pulse oximetry monitoring. Chest 2007; 132:852.</a></li><li><a class="nounderline abstract_t">Böhning N, Schultheiss B, Eilers S, et al. Comparability of pulse oximeters used in sleep medicine for the screening of OSA. Physiol Meas 2010; 31:875.</a></li><li><a class="nounderline abstract_t">Sharma S, Stansbury R. Sleep-Disordered Breathing in Hospitalized Patients: A Game Changer? Chest 2022; 161:1083.</a></li><li><a class="nounderline abstract_t">Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13:479.</a></li><li><a class="nounderline abstract_t">Cooksey JA, Balachandran JS. Portable Monitoring for the Diagnosis of OSA. Chest 2016; 149:1074.</a></li><li><a class="nounderline abstract_t">Kauta SR, Keenan BT, Goldberg L, Schwab RJ. Diagnosis and treatment of sleep disordered breathing in hospitalized cardiac patients: a reduction in 30-day hospital readmission rates. J Clin Sleep Med 2014; 10:1051.</a></li><li><a class="nounderline abstract_t">Chernyshev OY, McCarty DE, Moul DE, et al. A pilot study: portable out-of-center sleep testing as an early sleep apnea screening tool in acute ischemic stroke. Nat Sci Sleep 2015; 7:127.</a></li><li><a class="nounderline abstract_t">Nagubadi S, Mehta R, Abdoh M, et al. The Accuracy of Portable Monitoring in Diagnosing Significant Sleep Disordered Breathing in Hospitalized Patients. PLoS One 2016; 11:e0168073.</a></li><li><a class="nounderline abstract_t">Aurora RN, Patil SP, Punjabi NM. Portable Sleep Monitoring for Diagnosing Sleep Apnea in Hospitalized Patients With Heart Failure. Chest 2018; 154:91.</a></li><li><a class="nounderline abstract_t">Saletu MT, Kotzian ST, Schwarzinger A, et al. Home Sleep Apnea Testing is a Feasible and Accurate Method to Diagnose Obstructive Sleep Apnea in Stroke Patients During In-Hospital Rehabilitation. J Clin Sleep Med 2018; 14:1495.</a></li><li><a class="nounderline abstract_t">Ting J, Tan LL, Balakrishnan ID, et al. Watch-PAT versus level III device in diagnosing sleep disordered breathing in first myocardial infarction. Clin Respir J 2018; 12:2332.</a></li><li><a class="nounderline abstract_t">Farney RJ, Walker JM, Cloward TV, et al. Polysomnography in hospitalized patients using a wireless wide area network. J Clin Sleep Med 2006; 2:28.</a></li><li><a class="nounderline abstract_t">Wessendorf TE, Teschler H, Wang YM, et al. Sleep-disordered breathing among patients with first-ever stroke. J Neurol 2000; 247:41.</a></li><li><a class="nounderline abstract_t">Louis JM, Mogos MF, Salemi JL, et al. Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep 2014; 37:843.</a></li><li><a class="nounderline abstract_t">Lindenauer PK, Stefan MS, Johnson KG, et al. Prevalence, treatment, and outcomes associated with OSA among patients hospitalized with pneumonia. Chest 2014; 145:1032.</a></li><li><a class="nounderline abstract_t">Sharma S, Chowdhury A, Tang L, et al. Hospitalized Patients at High Risk for Obstructive Sleep Apnea Have More Rapid Response System Events and Intervention Is Associated with Reduced Events. PLoS One 2016; 11:e0153790.</a></li><li><a class="nounderline abstract_t">Wang LJ, Pan LN, Yan RY, et al. Obstructive sleep apnea increases heart rhythm disorders and worsens subsequent outcomes in elderly patients with subacute myocardial infarction. J Geriatr Cardiol 2021; 18:30.</a></li><li><a class="nounderline abstract_t">Lee CH, Khoo SM, Chan MY, et al. Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med 2011; 7:616.</a></li><li><a class="nounderline abstract_t">Ohmura T, Iwama Y, Kasai T, et al. Impact of predischarge nocturnal pulse oximetry (sleep-disordered breathing) on postdischarge clinical outcomes in hospitalized patients with left ventricular systolic dysfunction after acute decompensated heart failure. Am J Cardiol 2014; 113:697.</a></li><li><a class="nounderline abstract_t">Sorscher AJ, Caruso EM. Frequency of provision of CPAP in the inpatient setting: an observational study : "CPAP provision in the inpatient setting". Sleep Breath 2012; 16:1147.</a></li><li><a class="nounderline abstract_t">de Miguel-Díez J, Carrasco-Garrido P, Jiménez-García R, et al. Obstructive sleep apnea among hospitalized patients in Spain, analysis of hospital discharge data 2008-2012. Sleep Breath 2015; 19:841.</a></li><li><a class="nounderline abstract_t">Kamel G, Munzer K, Espiritu J. Use of CPAP in patients with obstructive sleep apnea admitted to the general ward: effect on length of stay and readmission rate. Sleep Breath 2016; 20:1103.</a></li><li><a class="nounderline abstract_t">Saini P, Klada E, Patel V, et al. Continuous positive airway pressure usage in hospitalized patients with known obstructive sleep apnea: discrepancy between admission pressure settings and laboratory-determined settings. Sleep Breath 2017; 21:347.</a></li><li><a class="nounderline abstract_t">Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med 2020; 8:359.</a></li><li><a class="nounderline abstract_t">Guralnick AS, Pant M, Minhaj M, et al. CPAP adherence in patients with newly diagnosed obstructive sleep apnea prior to elective surgery. J Clin Sleep Med 2012; 8:501.</a></li><li><a class="nounderline abstract_t">Liao P, Luo Q, Elsaid H, et al. Perioperative auto-titrated continuous positive airway pressure treatment in surgical patients with obstructive sleep apnea: a randomized controlled trial. Anesthesiology 2013; 119:837.</a></li><li><a class="nounderline abstract_t">O'Gorman SM, Gay PC, Morgenthaler TI. Does autotitrating positive airway pressure therapy improve postoperative outcome in patients at risk for obstructive sleep apnea syndrome? A randomized controlled clinical trial. Chest 2013; 144:72.</a></li><li><a class="nounderline abstract_t">Khayat RN, Javaheri S, Porter K, et al. In-Hospital Management of Sleep Apnea During Heart Failure Hospitalization: A Randomized Controlled Trial. J Card Fail 2020; 26:705.</a></li><li><a class="nounderline abstract_t">Khayat RN, Abraham WT, Patt B, et al. In-hospital treatment of obstructive sleep apnea during decompensation of heart failure. Chest 2009; 136:991.</a></li><li><a class="nounderline abstract_t">Alvi RM, Tariq N, Malhotra A, et al. Sleep Apnea and Heart Failure With a Reduced Ejection Fraction Among Persons Living With Human Immunodeficiency Virus. Clin Infect Dis 2018; 67:447.</a></li><li><a class="nounderline abstract_t">Mehta V, Vasu TS, Phillips B, Chung F. Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis. J Clin Sleep Med 2013; 9:271.</a></li><li><a class="nounderline abstract_t">Liao P, Wong J, Singh M, et al. Postoperative Oxygen Therapy in Patients With OSA: A Randomized Controlled Trial. Chest 2017; 151:597.</a></li><li><a class="nounderline abstract_t">Hollier CA, Harmer AR, Maxwell LJ, et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax 2014; 69:346.</a></li><li><a class="nounderline abstract_t">Sharma S, Mather P, Gupta A, et al. Effect of Early Intervention With Positive Airway Pressure Therapy for Sleep Disordered Breathing on Six-Month Readmission Rates in Hospitalized Patients With Heart Failure. Am J Cardiol 2016; 117:940.</a></li><li><a class="nounderline abstract_t">Konikkara J, Tavella R, Willes L, et al. Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation is associated with reduced readmission. Hosp Pract (1995) 2016; 44:41.</a></li><li><a class="nounderline abstract_t">Liu X, Lam DC, Chan KPF, et al. Prevalence and Determinants of Sleep Apnea in Patients with Stroke: A Meta-Analysis. J Stroke Cerebrovasc Dis 2021; 30:106129.</a></li><li><a class="nounderline abstract_t">Padeletti M, Green P, Mooney AM, et al. Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med 2009; 10:353.</a></li><li><a class="nounderline abstract_t">Sharma S, Mather PJ, Chowdhury A, et al. Sleep Overnight Monitoring for Apnea in Patients Hospitalized with Heart Failure (SOMA-HF Study). J Clin Sleep Med 2017; 13:1185.</a></li><li><a class="nounderline abstract_t">Farney RJ, McDonald AM, Boyle KM, et al. Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone. Eur Respir J 2013; 42:394.</a></li><li><a class="nounderline abstract_t">Sériès F, Kimoff RJ, Morrison D, et al. Prospective evaluation of nocturnal oximetry for detection of sleep-related breathing disturbances in patients with chronic heart failure. Chest 2005; 127:1507.</a></li><li><a class="nounderline abstract_t">Khayat R, Abraham W, Patt B, et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail 2012; 18:534.</a></li><li><a class="nounderline abstract_t">Van den Broecke S, Jobard O, Montalescot G, et al. Very early screening for sleep-disordered breathing in acute coronary syndrome in patients without acute heart failure. Sleep Med 2014; 15:1539.</a></li><li><a class="nounderline abstract_t">Carmona-Bernal C, Ruiz-García A, Villa-Gil M, et al. Quality of life in patients with congestive heart failure and central sleep apnea. Sleep Med 2008; 9:646.</a></li><li><a class="nounderline abstract_t">Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99:1435.</a></li><li><a class="nounderline abstract_t">Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007; 49:2028.</a></li><li><a class="nounderline abstract_t">Midgren B, Mared L, Franklin KA, et al. Cheyne-Stokes respiration is not related to quality of life or sleepiness in heart failure. Clin Respir J 2010; 4:30.</a></li><li><a class="nounderline abstract_t">Hagenah G, Zapf A, Schüttert JB. Cheyne-stokes respiration and prognosis in modern-treated congestive heart failure. Lung 2010; 188:309.</a></li><li><a class="nounderline abstract_t">Sano K, Watanabe E, Hayano J, et al. Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure. Eur J Heart Fail 2013; 15:1003.</a></li><li><a class="nounderline abstract_t">Aurora RN, Chowdhuri S, Ramar K, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 2012; 35:17.</a></li><li><a class="nounderline abstract_t">Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 2015; 373:1095.</a></li><li><a class="nounderline abstract_t">Aurora RN, Bista SR, Casey KR, et al. Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: "The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses". J Clin Sleep Med 2016; 12:757.</a></li><li><a class="nounderline abstract_t">Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000; 161:375.</a></li><li><a class="nounderline abstract_t">Hu S, Singh M, Wong J, et al. Anesthetic Management of Narcolepsy Patients During Surgery: A Systematic Review. Anesth Analg 2018; 126:233.</a></li><li><a class="nounderline abstract_t">Cavalcante AN, Hofer RE, Tippmann-Peikert M, et al. Perioperative risks of narcolepsy in patients undergoing general anesthesia: A case-control study. J Clin Anesth 2017; 41:120.</a></li><li><a class="nounderline abstract_t">Hershner S, Kakkar R, Chung F, et al. Narcolepsy, Anesthesia, and Sedation: A Survey of the Perioperative Experience of Patients With Narcolepsy. Anesth Analg 2019; 129:1374.</a></li><li><a class="nounderline abstract_t">Hershner S, Auckley D. Perioperative Management of Insomnia, Restless Legs, Narcolepsy, and Parasomnias. Anesth Analg 2021; 132:1287.</a></li><li><a class="nounderline abstract_t">Hershner S, Dauvilliers Y, Chung F, et al. Knowledge Gaps in the Perioperative Management of Adults With Narcolepsy: A Call for Further Research. Anesth Analg 2019; 129:204.</a></li><li><a class="nounderline abstract_t">Wang J, Greenberg H. Status cataplecticus precipitated by abrupt withdrawal of venlafaxine. J Clin Sleep Med 2013; 9:715.</a></li><li><a class="nounderline abstract_t">Langford J, Gross WL. Psychosis in the context of sodium oxybate therapy. J Clin Sleep Med 2011; 7:665.</a></li><li><a class="nounderline abstract_t">Schenck CH, Mahowald MW. Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units. Intensive Care Med 1991; 17:219.</a></li><li><a class="nounderline abstract_t">Gugger JJ, Wagner ML. Rapid eye movement sleep behavior disorder. Ann Pharmacother 2007; 41:1833.</a></li><li><a class="nounderline abstract_t">Goldstein C. Management of Restless Legs Syndrome/Willis-Ekbom Disease in Hospitalized and Perioperative Patients. Sleep Med Clin 2015; 10:303.</a></li></ol></div><div id="topicVersionRevision">Topic 106476 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23589584" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Increased prevalence of sleep-disordered breathing in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21344054" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evaluation of sleep disorders in the primary care setting: history taking compared to questionnaires.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10593776" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Performance of sleep histories in an ambulatory medicine clinic: impact of simple chart reminders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24392863" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sleep-disordered breathing in Hispanic/Latino individuals of diverse backgrounds. The Hispanic Community Health Study/Study of Latinos.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19690624" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21037995" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Analysis of hospital discharge data to characterize obstructive sleep apnea and its management in adult patients hospitalized in Canada: 2006 to 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25317085" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Risk of sleep apnea in hospitalized older patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25766715" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Obstructive Sleep Apnea in Obese Hospitalized Patients: A Single Center Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28476457" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Recognition and Treatment of Sleep-Disordered Breathing in Obese Hospitalized Patients May Improve Survival. The HoSMed Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19879459" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure: report of prevalence and patient characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25636743" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sleep disordered breathing and post-discharge mortality in patients with acute heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25084983" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16931151" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sleep apnea in acute coronary syndrome: high prevalence but low impact on 6-month outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20411688" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Frequency of sleep apnea in stroke and TIA patients: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22942502" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Obstructive sleep apnea affects hospital outcomes of patients with non-ST-elevation acute coronary syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23538745" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Sleep-disordered breathing and postoperative outcomes after elective surgery: analysis of the nationwide inpatient sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17320536" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Potentially life-threatening sleep apnea is unrecognized without aggressive evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32247716" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Undiagnosed OSA May Significantly Affect Outcomes in Adults Admitted for COPD in an Inner-City Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24572486" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The prevalence of obstructive sleep apnea in patients hospitalized for COPD exacerbation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35223103" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Characteristics of Obese Patients with Acute Hypercapnia Respiratory Failure Admitted in the Department of Pneumology: An Observational Study of a North African Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33180549" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sleep-disordered Breathing among Hospitalized Patients with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34246548" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Obstructive sleep apnea is highly prevalent in COVID19 related moderate to severe ARDS survivors: findings of level I polysomnography in a tertiary care hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26268508" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The prevalence and characteristics of obstructive sleep apnea in hospitalized patients with type 2 diabetes in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31929464" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Obstructive Sleep Apnea in Psychiatric Inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28490881" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18468307" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Sleep disordered breathing in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19484691" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Utility of daytime polysomnography for in-patients with suspected sleep-disordered breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11592744" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Sleep histories are seldom documented on a general medical service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22795717" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Screening of hospitalized patients at high risk of obstructive sleep apnea in general cardiology service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17557473" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Newly identified obstructive sleep apnea in hospitalized patients: analysis of an evaluation and treatment strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17646227" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Variations in physician interpretation of overnight pulse oximetry monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20505219" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Comparability of pulse oximeters used in sleep medicine for the screening of OSA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34673024" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sleep-Disordered Breathing in Hospitalized Patients: A Game Changer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28162150" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26539918" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Portable Monitoring for the Diagnosis of OSA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25317084" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diagnosis and treatment of sleep disordered breathing in hospitalized cardiac patients: a reduction in 30-day hospital readmission rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26527904" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A pilot study: portable out-of-center sleep testing as an early sleep apnea screening tool in acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27992566" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The Accuracy of Portable Monitoring in Diagnosing Significant Sleep Disordered Breathing in Hospitalized Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29684317" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Portable Sleep Monitoring for Diagnosing Sleep Apnea in Hospitalized Patients With Heart Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30176970" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Home Sleep Apnea Testing is a Feasible and Accurate Method to Diagnose Obstructive Sleep Apnea in Stroke Patients During In-Hospital Rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29729122" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Watch-PAT versus level III device in diagnosing sleep disordered breathing in first myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17557434" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Polysomnography in hospitalized patients using a wireless wide area network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10701896" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Sleep-disordered breathing among patients with first-ever stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24790262" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24371839" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prevalence, treatment, and outcomes associated with OSA among patients hospitalized with pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27168330" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hospitalized Patients at High Risk for Obstructive Sleep Apnea Have More Rapid Response System Events and Intervention Is Associated with Reduced Events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33613657" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Obstructive sleep apnea increases heart rhythm disorders and worsens subsequent outcomes in elderly patients with subacute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22171200" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Severe obstructive sleep apnea and outcomes following myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24342759" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Impact of predischarge nocturnal pulse oximetry (sleep-disordered breathing) on postdischarge clinical outcomes in hospitalized patients with left ventricular systolic dysfunction after acute decompensated heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22109806" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Frequency of provision of CPAP in the inpatient setting: an observational study : "CPAP provision in the inpatient setting".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25566944" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Obstructive sleep apnea among hospitalized patients in Spain, analysis of hospital discharge data 2008-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26946418" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Use of CPAP in patients with obstructive sleep apnea admitted to the general ward: effect on length of stay and readmission rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27796718" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Continuous positive airway pressure usage in hospitalized patients with known obstructive sleep apnea: discrepancy between admission pressure settings and laboratory-determined settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31839558" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23066360" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : CPAP adherence in patients with newly diagnosed obstructive sleep apnea prior to elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24195872" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Perioperative auto-titrated continuous positive airway pressure treatment in surgical patients with obstructive sleep apnea: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23287823" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Does autotitrating positive airway pressure therapy improve postoperative outcome in patients at risk for obstructive sleep apnea syndrome? A randomized controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32592897" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : In-Hospital Management of Sleep Apnea During Heart Failure Hospitalization: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19567491" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : In-hospital treatment of obstructive sleep apnea during decompensation of heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29534158" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Sleep Apnea and Heart Failure With a Reduced Ejection Fraction Among Persons Living With Human Immunodeficiency Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23493498" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28007620" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Postoperative Oxygen Therapy in Patients With OSA: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24253834" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26830259" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effect of Early Intervention With Positive Airway Pressure Therapy for Sleep Disordered Breathing on Six-Month Readmission Rates in Hospitalized Patients With Heart Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26691510" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation is associated with reduced readmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34601243" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Prevalence and Determinants of Sleep Apnea in Patients with Stroke: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18614398" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Sleep disordered breathing in patients with acutely decompensated heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28859720" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Sleep Overnight Monitoring for Apnea in Patients Hospitalized with Heart Failure (SOMA-HF Study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23100497" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15888821" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prospective evaluation of nocturnal oximetry for detection of sleep-related breathing disturbances in patients with chronic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22748486" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25308397" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Very early screening for sleep-disordered breathing in acute coronary syndrome in patients without acute heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18203661" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Quality of life in patients with congestive heart failure and central sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086966" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17512359" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20298415" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Cheyne-Stokes respiration is not related to quality of life or sleepiness in heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20012640" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Cheyne-stokes respiration and prognosis in modern-treated congestive heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23645499" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22215916" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26323938" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27092695" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: "The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10673174" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29257771" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Anesthetic Management of Narcolepsy Patients During Surgery: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28433385" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Perioperative risks of narcolepsy in patients undergoing general anesthesia: A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30540615" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Narcolepsy, Anesthesia, and Sedation: A Survey of the Perioperative Experience of Patients With Narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33857970" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Perioperative Management of Insomnia, Restless Legs, Narcolepsy, and Parasomnias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30882519" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Knowledge Gaps in the Perioperative Management of Adults With Narcolepsy: A Call for Further Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23853567" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22171207" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Psychosis in the context of sodium oxybate therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1744307" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17925503" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Rapid eye movement sleep behavior disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26329440" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Management of Restless Legs Syndrome/Willis-Ekbom Disease in Hospitalized and Perioperative Patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
